Predictors of postdischarge mortality among hospitalised children aged 5−14 years at tertiary hospitals in Tanzania: a prospective observational cohort study - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Factors associated with postdischarge death in children aged 5–14 years discharged from Tanzanian tertiary hospitals: a prospective observational cohort study

  • By

  • Elton Roman Meleki

  • Stella Mongella

  • Francis Fredrick Furia

  • October 8, 2026

Share

Clinical Scorecard: Factors associated with postdischarge death in children aged 5–14 years discharged from Tanzanian tertiary hospitals: a prospective observational cohort study

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Factors associated with postdischarge death in children aged 5–14 years discharged from Tanzanian tertiary hospitals
Key MechanismsFactors associated with postdischarge death included HIV infection, chronic kidney disease, symptoms lasting more than 2 weeks, leukocytosis, and discharge against medical advice.
Target PopulationPopulation described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • Among 744 children with known outcomes, 22 (2.9%) died within 3 months after discharge.
  • More than half of deaths occurred within 1 month of discharge; 13 (59.1%) occurred at home.
  • Reported associations with postdischarge death included HIV infection (HR 9.83), chronic kidney disease (HR 18.26), symptoms lasting more than 2 weeks (HR 4.7), leukocytosis (HR 7.94), and discharge against medical advice (HR 55.4).
  • Pneumonia and malignancies were each identified as probable causes of 18.2% of deaths.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Prospective cohort of 786 children aged 5–14 years admitted to paediatric wards at MNH, JKCI, and MOI; postdischarge outcomes were known for 744.

          The study did not evaluate or report a treatment or prescribing intervention.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content